Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD
View abstract on PubMed
Summary
This summary is machine-generated.This study identified numerous genetic variants (pQTLs) linked to blood protein levels in chronic obstructive lung disease (COPD) patients. Integrating these genetic factors improves understanding of COPD mechanisms and biomarker associations.
Area Of Science
- Genomics
- Biomarker Discovery
- Precision Medicine
Background
- Precision medicine for complex diseases like COPD requires understanding genetic, epigenetic, and environmental influences.
- Biomarker discovery is crucial for identifying disease progression and phenotypic diversity.
Purpose Of The Study
- To identify single nucleotide polymorphisms (SNPs) associated with blood protein quantitative trait loci (pQTLs) in COPD cohorts.
- To explore causal relationships between pQTLs, protein levels, and COPD clinical phenotypes.
- To compare pQTLs with expression quantitative trait loci (eQTLs) and assess their impact on disease prediction.
Main Methods
- Meta-analysis of two large cohorts (SPIROMICS, COPDGene) of current and former smokers with and without COPD.
- Identification and replication of pQTLs for 88 blood proteins.
- Conditional independence tests for causal inference between genotypes, biomarkers, and COPD phenotypes.
- Comparison of pQTL SNPs with previously reported eQTL SNPs.
Main Results
- Identified 527 significant pQTLs in 38% of tested blood proteins, with most SNPs being novel and distinct from eQTL SNPs.
- A single SNP (rs7041) explained 71%-75% of the variation in vitamin D binding protein (VDBP).
- Inclusion of pQTL SNPs improved the predictive value for emphysema, increasing variance explained (R2) from 0.3 to 0.4.
- Distant pQTLs at the ABO blood group locus were significant for five proteins.
Conclusions
- Protein quantitative trait loci (pQTLs) are frequent and explain significant variation in blood protein levels, differing from eQTLs.
- Integrating pQTLs alongside eQTLs is recommended for uncovering COPD disease mechanisms and improving biomarker-disease association studies.
- Attention to the ABO blood group locus is advised for large-scale blood biomarker studies.